XML 77 R49.htm IDEA: XBRL DOCUMENT v3.23.4
SHARE-BASED COMPENSATION (Tables)
 12 Months Ended
Oct. 31, 2023
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on our share-based compensation expenses for the three most recent fiscal years.

   
Year Ended
  
   
October 31,
2023
    
October 31,
2022
    
October 31,
2021
  
Expense reported in:
                  
     Cost of goods sold
  
$
1,259
    
$
868
    
$
446
  
     Selling, general, and administrative
    
5,962
      
4,803
      
4,446
  
     Research and development
    
780
      
637
      
456
  
Total expense incurred
  
$
8,001
    
$
6,308
    
$
5,348
  
                         
Expense by award type:
    
                 
Restricted stock awards
   $
 7,909     $
 5,800     $
 4,920  
Stock options
     1       298       218  
Employee stock purchase plan
     91       210       210  
Total expense incurred
   $
 8,001
     $
 6,308
     $
 5,348
  
                         
Income tax benefits of share-based compensation
  
$
715
    
$
449
    
$
233
  
Share-based compensation cost capitalized
  
$
-
    
$
-
    
$
-
  

Restricted Stock Awards Activity A summary of restricted stock award activity during 2023 and the status of our restricted stock awards as of October 31, 2023, is presented below.

Restricted Stock
  
Shares
    
Weighted-Average
Fair Value at
Grant Date
  
Outstanding at October 31, 2022
    
893,704
    
$
15.62
  
Granted
    
791,925
    
$
16.84
  
Vested
    
(417,432
)
  
$
14.98
  
Cancelled
    
(29,900
)
  
$
16.48
  
Outstanding at October 31, 2023
    
1,238,297
    
$
16.27
  
Expected to vest as of October 31, 2023
    
1,117,128
    
$
16.21
  
Additional Information on Restricted Stock Awards

The table below presents additional information on our restricted stock awards for the three most recent fiscal years.


   
Year Ended
  
   
October 31,
2023
    
October 31,
2022
    
October 31,
2021
  
Number of shares granted
    
791,925
      
654,224
      
564,800
  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
16.84
    
$
18.73
    
$
11.20
  
Compensation costs not yet recognized
   $
12,760     $
 8,949     $
 7,300  
Weighted-average amortization period (in years)
     2.8       2.7       2.6  
Fair value of awards for which restrictions lapsed
  
$
6,256
    
$
5,212
    
$
4,491
  
Shares outstanding at balance sheet date
     1,238,297       893,704
       929,147
  
Stock Options Activity

The table below presents a summary of stock options activity during 2023 and information on stock options outstanding at October 31, 2023.

 
Shares
    
Weighted-Average
Exercise Price
  
Weighted-Average
Remaining
Contractual Life
  
Aggregate
Intrinsic Value
  
Outstanding at October 31, 2022
    
614,001
    
$
9.74
          
Granted
    
-
    
$
-
          
Exercised
    
(137,226
)
  
$
8.24
          
Cancellations, forfeitures, and adjustments
    
(4,500
)
  
$
10.18
          
Outstanding at October 31, 2023
    
472,275
    
$
10.18
  
2.5 years
  
$
3,865
  
Exercisable at October 31, 2023
    
472,275
    
$
10.18
  
2.5 years
  
$
3,865
  
Expected to vest as of October 31, 2023
    
-
    
$
-
  
- years
  
$
-
  
Additional Information on Stock Option Awards

The table below presents additional information on stock option awards for the three most recent fiscal years.


   
Year Ended
  
   
October 31,
2023
    
October 31,
2022
    
October 31,
2021
  
Number of options granted in period
     -
       -
       -
  
Total intrinsic value of options exercised
  
$
1,654
    
$
5,108
    
$
1,910
  
Cash received from option exercises
  
$
1,101
    
$
5,275
    
$
3,441
  
Compensation cost not yet recognized
   $
 -     $
 13     $
 109  
Weighted-average amortization period for cost not yet recognized (in years)
     -       0.2       1.1